247 related articles for article (PubMed ID: 20524853)
21. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
J Infect Dis; 2004 Sep; 190(6):1076-83. PubMed ID: 15319856
[TBL] [Abstract][Full Text] [Related]
22. Thioredoxin as a biomarker for graft rejection in lung transplant recipients.
Patel JM; Hu H; Lu L; Deem A; Akindipe O; Brantly M; Block ER; Antony VB; Baz MA
Biomarkers; 2008 Aug; 13(5):486-95. PubMed ID: 18979641
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of respiratory viruses in bronchoalveolar lavage samples in a tertiary hospital.
Drieghe S; Ryckaert I; Beuselinck K; Lagrou K; Padalko E
J Clin Virol; 2014 Mar; 59(3):208-11. PubMed ID: 24447853
[TBL] [Abstract][Full Text] [Related]
24. CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction.
Weigt SS; Derhovanessian A; Liao E; Hu S; Gregson AL; Kubak BM; Saggar R; Saggar R; Plachevskiy V; Fishbein MC; Lynch JP; Ardehali A; Ross DJ; Wang HJ; Elashoff RM; Belperio JA
Am J Transplant; 2012 Feb; 12(2):477-84. PubMed ID: 22152000
[TBL] [Abstract][Full Text] [Related]
25. Simkania negevensis in bronchoalveolar lavage of lung transplant recipients: a possible association with acute rejection.
Husain S; Kahane S; Friedman MG; Paterson DL; Studer S; McCurry KR; Wolf DG; Zeevi A; Pilewski J; Greenberg D
Transplantation; 2007 Jan; 83(2):138-43. PubMed ID: 17264809
[TBL] [Abstract][Full Text] [Related]
26. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.
Charlson ES; Diamond JM; Bittinger K; Fitzgerald AS; Yadav A; Haas AR; Bushman FD; Collman RG
Am J Respir Crit Care Med; 2012 Sep; 186(6):536-45. PubMed ID: 22798321
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.
Ogimi C; Waghmare AA; Kuypers JM; Xie H; Yeung CC; Leisenring WM; Seo S; Choi SM; Jerome KR; Englund JA; Boeckh M
Clin Infect Dis; 2017 Jun; 64(11):1532-1539. PubMed ID: 28329354
[TBL] [Abstract][Full Text] [Related]
28. Surveillance bronchoscopy in children during the first year after lung transplantation: Is it worth it?
Benden C; Harpur-Sinclair O; Ranasinghe AS; Hartley JC; Elliott MJ; Aurora P
Thorax; 2007 Jan; 62(1):57-61. PubMed ID: 16928706
[TBL] [Abstract][Full Text] [Related]
29. Altered nonspecific lymphocyte cytotoxicity in bronchoalveolar lavage of lung transplant recipients: can it be useful in monitoring rejection or infection?
Shennib H; Lee AG; Serrick C; Giaid A
Transplantation; 1996 Nov; 62(9):1262-7. PubMed ID: 8932269
[TBL] [Abstract][Full Text] [Related]
30. Bronchoalveolar lavage in lung transplantation. State of the art.
Tiroke AH; Bewig B; Haverich A
Clin Transplant; 1999 Apr; 13(2):131-57. PubMed ID: 10202611
[TBL] [Abstract][Full Text] [Related]
31. Bronchoalveolar lavage fluid endotoxin elevation in human single lung transplant recipients during rejection.
Lambert SB; Frazier-Jessen MR; VanStedum S; Hahn EL; Filkins JP; Garrity ER; Kovacs EJ
Transpl Immunol; 1995 Mar; 3(1):81-5. PubMed ID: 7551984
[TBL] [Abstract][Full Text] [Related]
32. Quantitative detection of Epstein-Barr virus in bronchoalveolar lavage from transplant and nontransplant patients.
Costa C; Elia M; Astegiano S; Sidoti F; Terlizzi ME; Solidoro P; Botto S; Libertucci D; Bergallo M; Cavallo R
Transplantation; 2008 Nov; 86(10):1389-94. PubMed ID: 19034008
[TBL] [Abstract][Full Text] [Related]
33. Role of rhinovirus load in the upper respiratory tract and severity of symptoms in lung transplant recipients.
Ambrosioni J; Bridevaux PO; Aubert JD; Soccal P; Wagner G; Kaiser L
J Clin Virol; 2015 Mar; 64():1-5. PubMed ID: 25728070
[TBL] [Abstract][Full Text] [Related]
34. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study.
Riise GC; Kjellström C; Ryd W; Scherstén H; Nilsson F; Mårtensson G; Andersson BA
Eur Respir J; 1997 Aug; 10(8):1742-6. PubMed ID: 9272913
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages.
Malcolm E; Arruda E; Hayden FG; Kaiser L
J Clin Virol; 2001 Apr; 21(1):9-16. PubMed ID: 11255093
[TBL] [Abstract][Full Text] [Related]
36. Expression of gamma-IFN mRNA in bronchoalveolar lavage fluid correlates with early acute allograft rejection in lung transplant recipients.
Moudgil A; Bagga A; Toyoda M; Nicolaidou E; Jordan SC; Ross D
Clin Transplant; 1999 Apr; 13(2):201-7. PubMed ID: 10202618
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Performance of Multiplex Nucleic Acid Testing of Bronchoalveolar Lavage and Bronchial Wash Specimens for Respiratory Viral Pathogens.
Munigala S; Burnham CA; Anderson NW; Liang SY; Lawrence SJ; Warren DK
J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093393
[TBL] [Abstract][Full Text] [Related]
38. Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation.
De Hoyos A; Chamberlain D; Schvartzman R; Ramirez J; Kesten S; Winton TL; Maurer J
Chest; 1993 Jun; 103(6):1813-8. PubMed ID: 8404105
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients.
Reynaud-Gaubert M; Thomas P; Gregoire R; Badier M; Cau P; Sampol J; Giudicelli R; Fuentes P
Eur J Cardiothorac Surg; 2002 Jan; 21(1):60-6. PubMed ID: 11788258
[TBL] [Abstract][Full Text] [Related]
40. Nasopharyngeal viral PCR in immunosuppressed patients and its association with virus detection in bronchoalveolar lavage by PCR.
Lachant DJ; Croft DP; McGrane Minton H; Prasad P; Kottmann RM
Respirology; 2017 Aug; 22(6):1205-1211. PubMed ID: 28382762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
